ats-13-04
ats-13-02
ats-13-04
ats-13-02

ATS-13® Activity Assay

What is your testing algorithm for patients suspected of having thrombotic thrombocytopenic purpura (TTP)?

ATS-13 Activity Assay provides protocols to quantitatively measure ADAMTS-13 protease activity and determine the presence of inhibitory antibodies to ADAMTS-13 in human plasma.

ADAMTS-13 is the protease that cleaves von Willebrand Factor. Significant decreases or an absence of ADAMTS-13 activity can lead to the formation of ultra-large vWF fragments and trigger iIntravascular platelet aggregation and microthrombosis, causing the signs and symptoms of thrombotic thrombocytopenic purpura, TTP.

Quick and Easy

  • Set up in less than 10 minutes
  • Pre-diluted calibrators
  • Results in under 45 minutes

Sensitive

  • Utilizes fluorescence resonance energy transfer (FRET) technology with less test variability
  • % Activity and % Inhibition derived from a fluorescent endpoint

Research Use Only (RUO). Not for use in diagnostic procedures.

Resource Library

PACKAGE INSERTS (PI/ IFU), SAFETY DATA SHEETS (SDS), CERTIFICATES of ANALYSIS, LOT SPECIFIC FILES, and more can be accessed on our customer center.

Our Certifications

Related Products

pipetting-lab-04

Factor VIII Antibody Screen

luminex-lab-07

PF4 Enhanced® and PF4 IgG Assay​

Upcoming Events,
Webinars & Workshops

Upcoming Event

Webinar: Exploring the Luminex Single Antigen Bead Assay of Two Different Vendors

When

May 29th 2024

Where

Dijon, France

Upcoming Event

ISBT

When

June 23rd 2024

Where

Barcelona, Spain

Upcoming Event

Transfusion Education Event - ISBT

When

June 24th 2024

Where

Barcelona, Spain

Experience Our Virtual Lab

Contact your sales representative for a personal tour.
Werfen

5 Isnor Drive, Dartmouth. NS, Canada B3B 1M1

Call +1-800-552-2025 x6115

Email [email protected]